[1] Davidson BJ, Root WA, Trock BJ. Age and survival from squamous cell carcinoma of the oral tongue [J]. Head Neck, 2001, 23(4): 273-279. [2] Allocati N, Di Ilio C, De Laurenzi V. p63/p73 in the control of cell cycle and cell death [J]. Exp Cell Res, 2012, 318(11): 1285-1290. [3] Zheng HX, Cai YD, Wang YD, et al. Fas signaling promotes motility and metastasis through epithelial-mesenchymal transition in gastrointestinal cancer [J]. Oncogene, 2013, 32(9): 1183-1192. [4] Tremblay AM, Camargo FD. Hippo signaling in mammalian stem cells [J]. Semin Cell Dev Biol, 2012, 23(7): 818-826. [5] Karpowicz P, Perez J, Perrimon N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration [J]. Development, 2010, 137(24): 4135-4145. [6] Cherrett C, Furutani-Seiki M, Bagby S. The Hippo pathway: key interaction and catalytic domains in organ growth control, stem cell self-renewal and tissue regeneration [J]. Essays Biochem, 2012, 53: 111-127. [7] Pan D. The Hippo signaling pathway in development and cancer [J]. Dev Cell, 2010, 19(4): 491-505. [8] Zhao B, Li L, Lei Q, et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version [J]. Genes Dev, 2010, 24(9): 862-874. [9] Wisotzkey RG, Konikoff CE, Newfeld SJ. Hippo pathway phylogenetics predicts monoubiquitylation of Salvador and Merlin/nf2 [J]. PLoS One, 2012, 7(12): e51599. [10] Zhao B, Ye X, Yu J, et al. TEAD mediates YAP-dependent gene induction and growth control [J]. Genes Dev, 2008, 22(14): 1962-1971. [11] Landin Malt A, Cagliero J, Legent K, et al. Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin [J]. PLoS One, 2012, 7(9): e45498. [12] Liu-Chittenden Y, Huang B, Shim JS, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP [J]. Genes Dev,2012, 26(12): 1300-1305. |